Cancer genetics for the clinician: recommendations on screening for BRCA1 and BRCA2 mutations.
Level V
Where this comes from
- Record sourced from PubMed, PMID 10860223.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mutations in the BRCA1 and BRCA2 genes confer a greatly increased risk of breast cancer, ovarian cancer, and other malignant diseases. This paper offers recommendations about who should be screened for BRCA mutations, and insights into the ramifications of BRCA testing.